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Abstract
Regional hypoperfusion, associated with a reduction in cerebral metabolism, is a hallmark of Alzheimer’s disease (AD) and contributes to
cognitive decline. Cerebral perfusion and hence cognition can be enhanced by exercise. The present review describes ﬁrst how the effects of
exercise on cerebral perfusion in AD are mediated by nitric oxide (NO) and tissue-type plasminogen activator, the release of which is regulated by
NO. A conclusion of clinical relevance is that exercise may not be beneﬁcial for the cognitive functioning of all people with dementia if
cardiovascular risk factors are present.
The extent to which cardiovascular risk factors play a role in the selection of older people with dementia in clinical studies will be addressed in
the second part of the review in which the effects of exercise on cognition are presented. Only eight relevant studies were found in the literature,
emphasizing the paucity of studies in this ﬁeld. Positive effects of exercise on cognition were reported in seven studies, including two that
excluded and two that included patients with cardiovascular risk factors. These ﬁndings suggest that cardiovascular risk factors do not necessarily
undo the beneﬁcial effects of exercise on cognition in cognitively impaired people. Further research is called for, in view of the limitations of the
clinical studies reviewed here.
q 2005 Elsevier Ltd. All rights reserved.
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In the elderly population, there is a strong relationship
between the level of physical activity and cognition (Van
Gelder et al., 2004; Fratiglioni et al., 2004). The key question
whether this relationship is causal, however, remains to be
answered (Fratiglioni et al., 2004). For example, a period of
decreased physical activity that precedes the onset of dementia
could be either the cause of the dementia or be the result of the
prodromal cognitive impairment (Fratiglioni et al., 2004). One
way to answer the question about the causality is to perform
intervention studies.
In a recent meta-analysis of physical intervention studies,
Colcombe and Kramer (2003) provide convincing evidence
that aerobic ﬁtness training in older persons improves cognitive
functioning, especially executive-control processes. Although
the magnitude of the effects varied, a beneﬁcial impact of
aerobic exercise training was found in general, independent of
type, duration, or intensity of physical activity. Of the 18
intervention studies they considered, only two (Palleschi et al.,
1996; Powell, 1974) examined the effects of such training on a
group of older persons with cognitive impairment. In other
words, persons with dementia receive little attention in
physical exercise studies. Studies that do include older people
with dementia tend to deal with the effects of exercise on
functional mobility (MacRae et al., 1996; Teri et al., 1998)o r
sleep (Alessi et al., 1999; Namazi et al., 1995) rather than on
cognition. This is the more remarkable since cognition is most
vulnerable in older persons with dementia. One goal of the
present article is, therefore, to review the few clinical studies
that have examined the inﬂuence of exercise on cognition in
this population.
Literature searches were performed in Pubmed, Web of
Science, PsycINFO, and BioMed Central. In view of the small
number of intervention studies concerning the effects of
physical activity on cognition in people with dementia, all
studies in this ﬁeld were included irrespective of the aetiology
of the cognitive impairment and year of publication. The key
words used in the search included physical activity, exercise,
ﬁtness training, aerobic, physical therapy in combination with
cognition, cognitive function, cognitive functioning neuropsy-
chological, memory, executive functioning. These key words
were combined with the following words dementia, demented,
Alzheimer’sd i s e a s e , nursing home residents, cognitive
impairment, cognitively impaired, mild cognitive impairment,
memory impairment. The inclusion criteria were (1) studies
that reported on participants having some degree of cognitive
impairment or diagnosis of dementia (2) a programme focused
exclusively on exercise, physical activity or ﬁtness training; (3)
cognition as the dependent variable. Studies were excluded if
(1) they were not written in English; (2) no details were
reported on the cognitive status of the participants; (3) when
next to exercise, also another type of sensory stimulation was
offered, e.g. music. The combination of two types of sensory
stimulation may improve cognition in people with dementia
(Van de Winckel et al., 2004), but it remains obscure which
type of stimulation was (most) effective.
Clinical studies that provided sufﬁcient data for calculating
effect-sizes d (Cohen’s d: 0.20Zsmall, 0.50Zmoderate, and
0.80Zlarge) (Cohen, 1992) are labelled ‘Clinical studies A’
(see Table 1a). In case a control group was present, effect sizes
were calculated between groups; if a control group was absent
the effect size within the group is noted. Studies in which data
to calculate effect sizes are lacking are labelled ‘Clinical
studies B’ (see Table 1b).
Churchill and co-workers (2002) discussed in an excellent
review the results of experimental animal studies in which
responses to exercise, including synaptogenesis, neurogenesis,
glial plasticity, and vascular plasticity in the normal aging
brain were examined. In a transgenic mouse model of AD,
mice with the opportunity to exercise voluntarily on a running
wheel for ﬁve months showed a decrease in extracellular
amyloid-ß (Aß) plaques in the frontal cortex and hippocampus
(Adlard et al., 2005). In addition, the performance on the
Morris water maze was found to be improved indicating an
enhanced rate of learning (Adlard et al., 2005). In sum, in
animal experimental studies with both healthy mice and mice
with AD-like neuropathology, exercise has been found to
generate positive responses in the brain.
The question arises whether these plastic reactions to
exercise also occur in people with dementia. The second goal
of the present paper is to try to provide an answer to this
question by focusing on the relationship between exercise and
vascular plasticity, i.e. cerebral perfusion, particularly patients
with Alzheimer’s disease (AD). The reason for focusing on the
relationship between perfusion and exercise, particularly in
AD, is threefold: (1) cerebral perfusion is a good measure for
neural activity (Iadecola, 2004), (2) regional hypoperfusion,
associated with a reduction in cerebral metabolism (Attwell
and Iadecola, 2002; Wolf et al., 2001), is a hallmark of AD
(Miklossy, 2003) and contributes to cognitive decline
(Miklossy, 2003; Swaab, 1991, 2004), and (3) exercise has
been shown to exert a positive inﬂuence on cerebral perfusion
(Ide et al., 1999) and thus seems to be a good read out system
for effects.
A comprehensive overview of cerebral perfusion in AD is
beyond the scope of this paper. Since endothelium-derived
factors play a pivotal role in the regulation of cerebral
perfusion (Farkas and Luiten, 2001), a literature search was
performed for studies that examined those factors with respect
to AD. Subsequently, the factors resulting from that search had
to be studied in relation to the following key words cerebral
perfusion/cerebral blood ﬂow/cerebral hypoperfusion and
exercise/physical activity/aerobic activity. Only nitric oxide
(NO), a potent vasodilator (Huang et al., 1995), met those
criteria and will thus be discussed.
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Clinical studies A
Study Sample
(men/women)
N Age Design Type of intervention Dependent variables Results
Diesfeldt and
Diesfeldt-Groe-
nen-wijk, 1977
Psychogeriatric
patients with
mental and
physical handi-
caps (6/34)
40 MZ82 Experimental
group/control
group;
repeated
measures
15 min bending/stretching, 25 min
playing a game consisting of throwing
and kicking a ball and knocking down
skittles
Free recall task (immediate free
recall and total-recall score); post-
ing-box task; recognition task
Signiﬁcant increase in total recall
score (dZ0.23) in the experimental
group, other measures did not
change signiﬁcantly
Friedman and
Tappen, 1991
Nursing home
residents with
probable AD
(NINCDS-
ADRDA criteria
and MMSE
scores !19) (17/
13)
30 O60 Experimental
group/control
group;
repeated
measures
30-min walk three times a week for 10
weeks
Communication scale for the cog-
nitively impaired
a; communication
observation scale for the cognitively
impaired (COS)
Improvement on the COS (dZ1.06)
in the experimental group. Conver-
sation only did not result in a
signiﬁcant improvement
Palleschi et al.,
1996
Males diagnosed
with possible AD
(NINCDS-
ADRDA criteria,
GDS phase 4 or 5,
MMSE
b score
18–21) (0/15)
15 MZ74.0
SDZ1.5
Single group;
repeated
measures
Exercise on a cycloergometer (heart
rate at C/K70% of max pulse rate)
20 min exercise 3 days a week, for 3
months
Test of attentional matrix; verbal
span test; supraverbal span test
c;
MMSE
Signiﬁcant improvement on all
tasks (dZ1.52, dZ1.73, dZ2.71,
dZ1.94, respectively)
Powell, 1974 Geriatric mental
patients (13/17)
20 MZ69.3 (59–89) Two treat-
ment groups/
one control
group;
repeated
measures
Mild exercise: brisk walking, cal-
listhenics, rhythmical movements
social therapy group: social interaction
and music both treatment groups 1 h a
day, 5 days a week, for 12 weeks
Wechsler memory scale (WMS)
d
Raven’s progressive matrices
(PMT)
e memory for designs test
f;
nurses observation scale for inpati-
ent evaluation
g;geriatric assessment
scale
h
Signiﬁcant improvement in the
exercise group on the WMS (dZ0.
14) and PMT (dZ0.59). No changes
in the social therapy group
Scherder et al.,
2004
Older persons
with mild cogni-
tive impairment
(MMSE score 7–
12) (38/5)
43 Gr. I: MZ84
SDZ6.4 Gr. II:
MZ89 SDZ2.4
Gr. III: MZ86
SDZ5.1
Two treat-
ment groups/
one control
group;
repeated
measures
Walking group: self-paced slow
walking with an aid hand and face
exercises group: performing hand
movements and producing facial
expressions) control group: continued
receiving social visits or continuance
of normal social activities intervention
took place for 30 min a day, three
times a week, for 6 weeks
Category naming; trailmaking
(TMT) A and B
i; digit span and
visual memory span from the
Wechsler memory scale-revised
j;
verbal learning and memory test
k;
face recognition and picture recog-
nition from the rivermead beha-
vioural memory test
l
Improvement in tasks appealing to
executive functioning, i.e. verbal
ﬂuency and TMT in the walking
group (dZ0.42 and dZ0.46, resp)
and the hand and face group (dZ0.
59 and dZ0.13, resp) compared to
the control group
Characteristics of studies examining the effects of physical activity on cognition in cognitively impaired elderly. AD, Alzheimer’s disease; ADRDA, Alzheimer’s disease and related disorders association;
GDS, global deterioration scale; h, hour; M, mean; min, minutes; MMSE, mini mental state examination; NINCDS, national institute of neurological and communicative disorders and stroke; resp, respectively;
SD, standard deviation.
a Tappen, 1988.
b Folstein et al., 1975.
c Spinler and Tognoni, 1987.
d Wechsler, 1945.
e Raven, 1965.
f Graham and Kendall, 1960.
g Ho ¨nigfeld et al., 1966.
h Plutchik et al., 1970.
i Reitan and Wolfson, 1985.
j Wechsler, 1984.
k Mulder et al., 1995.
l Wilson et al., 1987.
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41. Outline of this review
First of all, studies on the relationship between hypoperfu-
sion, nitric oxide, cognition, and exercise in AD are described.
These studies lead to the important but rather unexpected
conclusion of clinical relevance that exercise may not be
beneﬁcial for the cognitive functioning of all people with
dementia but may depend on the presence of cardiovascular
risk factors. These studies will be described ﬁrst. The extent to
which cardiovascular risk factors play a role in the selection of
older people with dementia in clinical studies will be addressed
in the second part of the review in which the effects of exercise
on cognition are presented.
2. Hypoperfusion, nitric oxide, cognition and exercise
in Alzheimer’s disease
First, the focus will be on cerebral (hypo) perfusion, in
relation to neural activity, exercise, hypometabolism and
cognition. Subsequently, nitric oxide (NO) and tissue-type
plasminogen activator, the release of which is regulated by
NO will be discussed with respect to hypoperfusion and
exercise in AD.
3. Cerebral (hypo) perfusion in relation to neural activity,
exercise, hypometabolism, and cognition
3.1. Cerebral perfusion and neural activity
During neuronal activity, an increase of oxygen usage is
followed within a few seconds by an increase in cerebral
blood ﬂow (CBF) (Attwell and Iadecola, 2002). An increase
in oxygen and glucose uptake is indicative for enhanced
cerebral metabolism (Ide and Secher, 2000). As alterations
in regional cerebral metabolism can be inferred from
measurements of regional cerebral perfusion (Wolf et al.,
2001), cerebral perfusion is frequently used as a global
measure for neural activity in brain imaging studies (Wolf
et al., 2001; Iadecola, 2004). Fluctuations in cerebral
perfusion are maintained by cerebral autoregulation, an
important protective mechanism that ensures near-constant
CBF (Baumbach and Heistad, 1983). In autoregulation, the
arterial-arteriolar bed actively adjusts the caliber of its
Table 1b
Clinical studies B
Study Sample
(men/women)
N Age Design Type of interven-
tion
Dependent variables Results
Linden-
muth and
Moose,
1990
People with
Alzheimer’s
disease (27/16)
43 MZ82.8
(65–98)
Experimental
group/control
group; repeated
measures
Experimental
group: somatic
and isotonic-
relaxation exer-
cises for 8 weeks
Control group: no
intervention
Cognitive abilities screening test Experimental group
showed signiﬁcant
change
Rolland
et al., 2000
People with
probable AD
(NINCDS-
ADRDA cri-
teria) (13/10)
23 MZ78
(71–92)
Single group Endurance exer-
cise: walking,
exercise bicycle
for 5–12 weeks
(MZ7) for
35 min (10–
80 min)
Activities of daily living scale
a;
instrumental activities of daily liv-
ing scale
b; MMSE; neuropsychia-
tric inventory
c; zarit scale
d; mini-
nutritional assessment
e; tinetti test
f
Improved nutritional
status, improved cogni-
tive function, improve-
ment in behavioural
problems
Sobel, 2001 People with a
clinical AD
diagnosis
(MMSE
g scores
8–25) (22/28)
50 MZ82
(62–99)
Two separate
days two treat-
ment groups
design Ass 1,
followed
directly Ass 2 en
then 4–9 days
later Ass 3
Cognitive:
20 min of Bingo
Physical: 20 min
of walking or arm
and leg exten-
sions
Boston naming test and word list
recognition test from the CERAD
h
Cognitive stimulation
enhanced performance
on both tasks, whereas
physical intervention
did not reach statistical
signiﬁcance
Characteristics of studies examining the effects of physical activity on cognition in cognitively impaired elderly. AD, Alzheimer’s disease; ADRDA, Alzheimer’s
disease and related disorders association; Ass, assessment; M, mean; min, minutes; MMSE, mini mental state examination; NINCDS, national institute of
neurological and communicative disorders and stroke; SD, standard deviation.
a Katz, 1983.
b Lawton and Brody, 1969.
c Cumming et al., 1994.
d Zarit et al., 1982.
e Guigoz et al., 1994.
f Tinetti et al., 1988.
g Folstein et al., 1975, 1983.
h The Consortium to Establish a Registry for Alzheimer’s disease, 1987.
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(CPP) by dilating when CPP decreases and constricting
when CPP increases (Daley et al., 2004).
3.2. Cerebral perfusion and exercise
Changes in peripheral cardiovascular activity reﬂected in
increased heart rate (HR) and mean arterial blood pressure
(MAP) cause an increase in CBF in various cortical and
subcortical brain areas in healthy volunteers (Critchley et al.,
2000). During isometric exercise, an increase in CBF was
observed in the right anterior cingulate cortex (ACC),
cerebellar vermis and brain stem. CBF appeared to be
dependent on the extent of HR and MAP increase: for example,
a higher MAP was associated with a greater CBF in the ACC
and insula, whereas a lower MAP enhanced the CBF in e.g. the
hippocampus and medial temporal gyrus. Similarly, CBF
showed a speciﬁc positive relation with HR with respect to the
pons and a speciﬁc negative correlation concerning middle
frontal gyrus, cingulate, orbitofrontal cortex, and amygdala
(Critchley et al., 2000).
In addition to isometric exercise, CBF velocity is increased
in healthy participants by dynamic activities such as rowing
(Pott et al., 1997) and cycling (Hellstro ¨m et al., 1996). Even by
submaximal cycling CBF (Jørgensen et al., 1992)a n d
metabolism (Ide et al., 1999) increased. In the primary motor
cortex of rats, growth of capillaries as well as enhanced
cerebral perfusion was observed as a result of prolonged
exercise (Swain et al., 2003).
3.3. Cerebral hypoperfusion and hypometabolism in AD
A reduction in cerebral metabolism is accompanied by a
decrease in CBF (Prunell et al., 2004). Of note isthat there is no
agreement on the question whether reduced cerebral metab-
olism in AD precedes hypoperfusion or vice-versa. It is
suggested that a decrease of cerebral perfusion leads to
hypometabolism (De la Torre, 2002), whereas others claim
that a reduced metabolism is the cause of hypoperfusion
(Meyer et al., 2000).
Decreases in the cerebral metabolic rate for glucose and
hypoperfusion have consistently been observed in the tempor-
oparietalcortexinAD(Warkentinetal.,2004)whereasdifferent
levels of hypoperfusion have been found in the frontal and
occipital cortex of different AD patients (Warkentin et al.,
2004). More speciﬁcally, participants who developed AD late
showed decreased perfusion in the hippocampal-amygdaloı ¨d
complex, the anterior and posterior cingulate and the anterior
thalamus (Johnson et al., 1998; Matsuda, 2001). Of note is that
glucose hypometabolism has been observed even in the
preclinical stage of dementia for example in the temporal
lobe, posterior cingulate gyrus and precuneus (Reiman et al.,
1965;Matsuda,2001;Swaabetal.,2002).Hypoperfusionisalso
considered to be evidence for cerebromicrovascular pathology
underlying AD (De la Torre, 2002) Cerebral hypoperfusion
tends to lead to leuko-araiosis and cortical watershed infarcts,
which may exacerbate cognitive decline (Miklossy, 2003).
A protein which plays a major role in cerebral perfusion and
metabolism and is a known risk factor for sporadic AD, is
apolipoprotein E4 (ApoE4) (Corder et al., 1993). ApoE4
genotype appears not only to be involved in a decreased
metabolism in AD (Salehi et al., 1998), but also in a decreased
metabolism in ApoE4 carrying control subjects (Dubelaar
et al., 2004). In AD, ApoE4 genotype is accompanied by a
decrease in brain blood ﬂow velocity (Lehtovirta et al., 1998)
and enhances cerebrovascular amyloidogenesis (Martel et al.,
1997), i.e. extracellular accumulation of Ab (Parihar and
Hemnani, 2004). Cerebrovascular amyloidogenesis is directly
related to cerebral amyloid angiopathy (CAA) (Suzuki et al.,
1994), i.e. the deposition of e.g. Ab in the vessel walls of the
cerebral vasculature (Weller and Nicoll, 2003). In other words,
ApoE4 increases the risk for CAA (Weller and Nicoll, 2003)
and an etiological relationship between CAA and vascular
lesions, in particular intracerebral hemorrhage, has been
observed in AD (Weller and Nicoll, 2003). ApoE4 has been
associated with a reductionin CBF in the parietal, temporal and
occipital areas in AD (Lehtovirta et al., 1998; Matsuda, 2001),
together with a reduction in regional cerebral metabolic rate for
glucose in the posterior cingulate, and the parietal, temporal,
and prefrontal regions (Van Dyck, 2004).
3.4. Cerebral hypoperfusion and cognition in AD
Several studies indicate that a signiﬁcant correlation
between hypoperfusion and cognitive dysfunction in AD.
Hypoperfusion and the scores on the Cambridge Cognitive
Examination (CAMCOG) (Roth et al., 1986) were signiﬁcantly
correlated (Tsolaki et al., 2001). In a study using multiple
regression analysis, left posterior temporal regional CBF
(rCBF) was a predictor of performance on the clock drawing
test (Ueda et al., 2002). In addition, correlations were found
between the MMSE scores and hypoperfusion in frontal,
parietal en temporal cortex (Jagust et al., 1997; Tsolaki et al.,
2001; Ushijima et al., 2002). More speciﬁcally, only items
appealing to attention/calculation showed a decline in CBF in
the frontal cortex; all other items covering e.g. orientation and
recall were associated with a decreased CBF in the posterior
brain regions (Ushijima et al., 2002). In another study, rCBF in
the right posterodorsal anterior and superior prefrontal cortex
and the inferior parietal cortex was lower in a group of AD
patients in whom the condition was progressing rapidly
(Nagahama et al., 2003). Lower perfusion rates correlated
with poorer performance on the MMSE.
4. Nitric oxide in relation to hypoperfusion and exercise
in Alzheimer’s disease
4.1. Nitric oxide and hypoperfusion
A key factor associated with cerebral hypoperfusion in AD
is a dysfunction of nitric oxide (NO) metabolism (Selley, 2003;
Churchill et al., 2002). NO, derived from vascular endothelial
nitric oxide synthase (eNOS), plays a pivotal role in cerebral
perfusion by its inﬂuence on vascular tone, blood pressure, and
L. Eggermont et al. / Neuroscience and Biobehavioral Reviews 30 (2006) 562–575 566vascular homeostasis (Huang et al., 1995; Kubes and Granger,
1992). Cerebral autoregulation is mediated by NO (White
et al., 2000). Moreover, NO reduces the risk for atherosclerosis
and thrombosis and improves blood ﬂow by lowering stress on
the blood vessel wall, thus protecting endothelial cell function
(Maxwell, 2002).
It is suggested that AD-related hypoperfusion disturbs basal
NO levels, causing alterations in the endothelium and inducing
vascular injury (Cooke and Dzau, 1997). More speciﬁcally, it is
presumed that when the cerebral perfusion decreases below a
certain critical level, eNOS tries to maintain vascular
homeostasis by upregulating NO (De la Torre, 2002). In failing
to do so, NO becomes deregulated, damages the endothelial
cells and impairs glucose transport to the brain (Chen et al.,
1999). This vicious circle is presented in Fig. 1 (left side).
Subsequently, as a result of deterioration in NO homeosta-
sis, oxidative alterations may contribute to cell death
(Ferna ´ndez-Vizarra et al., 2004). Not only the surpassing of a
critical level of brain perfusion disturbs NO production and
contributes to AD neuropathology. Selley (2003) observed that
inhibition of NO production also results from increased levels
of homocysteine in the blood of AD patients. A high level of
homocysteine is a risk factor for cardiovascular disease
(Herrmann, 2001).
NO shows a close relationship to several neurotransmitter
systems. For example, the relationship between NO and the
nicotinic cholinergic system is reﬂected in the glutamate/nitric
oxide synthase (NOS)/soluble guanylyl cyclase (sGC)
pathway. More speciﬁcally, data suggest that the NOS/sGC
pathway is activated by a presynaptic action of nicotine,
resulting in among others hippocampal excitation (Fedele and
Raiteri, 1999). Activation of nicotinic acetylcholine
receptors—with consequent neural vasodilatation—contrib-
utes to an increase in CBF and NO production in the
hippocampus of conscious rats (Nakajima et al., 2003). The
entire cortical mantle including the hippocampus is densely
innervated by a very ﬁne NOS positive ﬁbre network that ﬁnds
its origin in scattered NOS interneurons. From the ﬁndings of
Nakajima and co-workers (2003) it can be concluded that basal
forebrain and medial septal cholinergic neurons have direct
projections onto the NOS positive interneurons and this way
have a well developed access to vasodilation mechanisms via
release of NO. Such a neuronal organization of cerebrovascular
innervation was also concluded from studies by Moro and
colleagues (1995) who demonstrated co localization of NOS
and muscarinic receptors in interneurons in neocortical regions
projecting onto cerebral microvessels (Hamel, 2004). Taken
together these experimental studies point to a potent basal
forebrain cholinergic inﬂuence on cortical blood ﬂow
regulation mediated by NO production through NOS inter-
neurons provided with both nicotinic and muscarinic postsyn-
aptic receptorsystems (Harkany et al., 2000). It is noteworthy
that a cholinergic denervation of NOS expressing interneurons
and cortical microvessels has been found in AD patients
(Tong and Hamel, 1999; Hamel, 2004), particularly in the
temporal cortex (Tong and Hamel, 1999). There are other
Fig. 1. NO and t-PA in AD. Alzheimer’s disease (AD)—related hypoperfusion disturbs basal nitric oxide (NO) levels, and hypoperfusion below a critical level leads
to dysfunctional upregulation of NO (De la Torre, 2002). Both processes increase the damage to the endothelial cells, resulting in vascular injury and initiating a
vicious circle (Cooke and Dzau, 1997). Since the release of tissue-type plasminogen activator (t-PA) is regulated by NO, NO dysfunction could also result in a
decreased t-PA activity (Schini-Kerth, 1999). Reduced t-PA causes reduced plasmin activity which aggravates accumulation of amyloid b peptide (Ab) in AD.
Increase of Ab can enhance inﬂammation and upregulation of t-PA inhibitors, leading to a vicious circle (Tucker et al., 2002).
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(Tong and Hamel, 2000). However, since a close relationship
between the nitrergic system and NO in AD is lacking, this
system will not be discussed here.
In sum, cerebral perfusion is highly dependent of NO and
NO metabolism is severely affected in AD.
4.1.1. Tissue-type plasminogen activator and hypoperfusion
In endothelial cells, NO regulates the release of tissue-type
plasminogen activator (t-PA) (Schini-Kerth, 1999), an enzyme
that plays a crucial role in preventing thrombosis (Muldowney
and Vaughan, 2002). The main function of t-PA is to convert
plasminogen—an inactive proenzyme (Lijnen and Collen,
1997)—into plasmin (Melchor et al., 2003), which in turn
degrades ﬁbrin clots in the circulation (Lijnen and Collen,
1997; Muldowney and Vaughan, 2002). Plasmin formation in
the pericellular environment takes place by another plasmino-
gen activator: the urokinase-type plasminogen activator (u-PA)
(Lijnen and Collen, 1997). Fibrinolytic activity induced by
vascular endothelial growth factor (VEGF), a pivotal angio-
genic growth factor (Carmeliet, 2000), is dependent on u-PA
(Prager et al., 2004).
Amyloid b (Ab) peptide, a product of Ab precursor protein,
causes in normal aging an upregulation of t-PA in combination
with u-PA in rat. This results in an increase in plasmin activity
which, in turn, degrades Ab (Tucker et al., 2000, 2002). An
increase in Ab, a neuropathological hallmark of AD
(Koistinaho and Koistinaho, 2005), is associated with an
upregulation of t-PA inhibitors and consequently with a
decrease in t-PA activity, particularly in areas that are most
vulnerable to AD, i.e. the hippocampus and amygdala
(Melchor et al., 2003). Tucker and co-workers (2002) further
propose a vicious circle, implying that by inﬂammation in AD,
inhibitors of t-PA and u-PA are increased. The increase in t-PA
and u-PA inhibitors would reduce plasmin activity, which
causes an increase in Ab levels and a further augmentation of
inﬂammation. This vicious circle is presented in Fig. 1 (right
side). Furthermore, the suggestion that t-PA and related
plasmin might also be able to enhance Ab activity and,
hence, neurotoxicity could not be conﬁrmed in rat (Tucker
et al., 2000). In addition, in the human AD hippocampus, there
was no evidence for a local inhibitory effect of the amyloid
containing plaques on neuronal metabolism (Salehi et al.,
1998).
Plasmin, generated by t-PA activity, degrades other
proteins like laminin (Chen and Strickland, 1997). Lami-
nin—a protein produced by Schwann cells—plays a crucial
role in the development of the peripheral and central nervous
system, among others by promoting neurite outgrowth
(Matsuda et al., 2002), Schwann cell migration (Anton
et al., 1994) and the formation of myelin (Eldridge et al.,
1989). Laminin is expressed in the hippocampus, more
speciﬁcally in CA1–CA3 and the dentate gyrus (Chen and
Strickland, 1997). In AD, laminin interacts with Ab peptide,
attenuating the aggregation of Ab possibly by inhibition of Ab
ﬁbril formation (Monji et al., 2000) and, hence, decreasing its
presumed neurotoxicity (Morgan and Inestrosa, 2001).
However, in ischaemic lesions, that are also a neuropatholo-
gical hallmark of AD (Koistinaho and Koistinaho, 2005),
plasmin degrades laminin and causes neuronal damage in
mice (Wang et al., 1998; Nagai et al., 1999) (see Fig. 2). One
mechanism underlying the increase in plasmin is that
ischaemic lesions overstimulate glutamate receptors which
mediate the enhancement of the synthesis of t-PA (Chen and
Strickland, 1997). In other words, degradation of laminin,
which will occur by an increase in t-PA in patients with
ischaemic lesions after stroke and particularly after relatively
small infarcts (Wang et al., 1998) might lead to further
neuronal loss (Chen and Strickland, 1997). In contrast to a
high level of t-PA which enhances cell death in patients with
cerebral ischaemia, a low level of plasminogen in mice causes
an increase in intravascular deposition of ﬁbrin that increases
infarct size (Nagai et al., 1999). The resulting high
concentrations of laminin might also have a neurotoxic effect
(Liesi et al., 1989).
Taken together, activity of t-PA and u-PA enhances the
production of plasmin which, in turn, is able to degrade Ab.
However, plasmin may also cause a decline of laminin, a
protein that decreases neurotoxicity in AD. Not only a too low
level of laminin, but also a high laminin concentration could
enhance neuronal damage.
Fig. 2. Role of t-PA, plasmin and laminin in ischaemic lesions. Ischaemic
lesions, part of the neuropathology of AD (Koistinaho and Koistinaho, 2005),
overstimulate glutamate receptors, resulting in (1) enhanced synthesis of t-PA,
(2) an increase in plasmin, (3) degradation of laminin (Wang et al., 1998) and
(4) neuronal loss (Chen and Strickland, 1997). Exercise leads to an
upregulation of NO (Endres et al., 2003) and increases cerebral perfusion
which could attenuate endothelial dysfunction in AD. Exercise enhances t-PA
(Smith et al., 2003) and consequently plasmin activity, stimulating degradation
of Ab and hence reducing neuronal damage. On the other hand, in the presence
of ischaemic lesions, the increased plasmin activity may degrade laminin,
increasing neuronal damage (Chen and Strickland, 1997).
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Animal experimental studies show a positive relationship
between exercise, nitric oxide, and cardio- and cerebrovas-
cular functioning (Endres et al., 2003). Mice with cerebral
ischaemia due to occlusion of the middle cerebral artery
that participated in a running group showed an upregulation
of eNOS accompanied by vasodilatation and a signiﬁcant
reduction in the size of the lesion, brain swelling, and
sensory-motor deﬁcits. These effects were not observed in
non-running mice. Of note here is that irrespective of the
nature of running, i.e. voluntary or trained, the rCBF
increased signiﬁcantly in the posterior brain regions, with
high values in the hippocampus (Endres et al., 2003).
Enhancing the release of NO might also contribute to anti-
inﬂammatory processes, as NO-releasing ferutic acid
derivative was effective in the reduction of microglia
activation in the temporal lobes of rats (Wenk et al.,
2004). An important point that needs further examination is
that serotoninergic dysfunction resulting in a hyposerotoni-
nergic condition—characteristic for AD (Meltzer et al.,
1998)—causes a supersensitivity to NO (Srikiatkhachorn
et al., 2000), implying that even mild physical activity
could result in beneﬁcial effects in AD.
Some support for a relationship between exercise and the
cholinergic system emerges from animal experimental studies,
in which walking signiﬁcantly increased release of acetyl-
choline in conscious rats (Kurosawa et al., 1993). Interestingly,
the higher the walking speed, the higher the cholinergic-
induced increase in CBF in the hippocampus (Nakajima et al.,
2003).
Finally, exercise may attenuate the endothelial dysfunction
caused by high levels of homocysteine (Hayward et al., 2003),
although it may be dependent on the duration and intensity of
exercise. Strenuous exercise may even lead to a homocysteine
increase in recreational endurance athletes (Herrmann et al.,
2003).
In short, physical activity leads to enhanced NO release
which may generate improved cerebrovascular function, may
enhance anti-inﬂammatory activity, and may lead to increased
acetylcholine release.
4.2.1. Tissue-type plasminogen activator and exercise
Smith and co-workers (2003) observed that the endothelium
of the forearm is less able to release t-PA antigen in older
persons with a low level of physical activity. Interestingly, the
capacity of the endothelium to release t-PA can be restored
after a period of aerobic exercise, particularly walking (Smith
et al., 2003). These authors suggest that the increase in t-PA
might restore endothelial ﬁbrinolytic function which is
diminished in aging. The increase in t-PA might be due to an
increased arterial pressure and pulsatile ﬂow during physical
activity. Although Smith and colleagues (2003) made their
observations on the forearm, we hypothesize that their ﬁndings
could be generalized to the cardiovascular condition, and hence
the perfusion of the brain.
In sum, an increase of t-PA by means of exercise may
restore endothelial ﬁbrinolytic function and improve cerebral
perfusion.
5. Exercise and cognition in older persons with dementia:
clinical studies A and B
5.1. Clinical studies A
In one of the earliest reports on this topic, a group of 20
psychogeriatric patients underwent an acute bout of exercise
for 40 min and showed a signiﬁcant improvement in memory
performance (greater retrieval capacity) compared with a
control group (Cohen’s dZ0.23) (Diesfeldt and Diesfeldt--
Groenendijk, 1977). Cardiovascular risk factors were not
controlled for. A few studies have been described in which
persons with dementia were given exercise for a longer
period. In a randomised controlled study, 20 geriatric mental
patients were divided into two treatment groups, one group
being given conventional social therapy and one exercise
therapy, and one control group (Powell, 1974). Patients with
cardiovascular risk factors such as hypertension were
excluded from the study. After 12 weeks of treatment the
exercise group showed improved performance on the
Progressive Matrices Test (Raven, 1965) (Cohen’s dZ0.59)
and the Wechsler Memory Scale (Wechsler, 1945) (Cohen’s
dZ0.14) compared with the control group. The higher scores
on both tests implied that global intellectual functioning and
memory improved. The results of another memory test and
two behavioural assessments did not show signiﬁcant
improvement. In another study, 15 males diagnosed with
possible AD exercised on a cycle ergometer (Palleschi et al.,
1996). No information was provided about the patients’
cardiovascular condition. Their performance on the test of the
attentional matrix (Spinler and Tognoni, 1987) (Cohen’s dZ
1.52), the verbal span test (Spinler and Tognoni, 1987)
(Cohen’s dZ1.73), the supraverbal span test (Spinler and
Tognoni, 1987) (Cohen’s dZ2.71) and the Mini Mental State
Examination (MMSE) (Folstein et al., 1975) (Cohen’s dZ
1.94) were found to have improved after the intervention
period. These treatment effects suggest an improvement in
attention en global cognitive functioning. It should be noted
however that a control group was lacking in this study.
Friedman and Tappen (1991) reported on 30 moderate to
severe AD patients who took part in either a walking
programme or a conversation programme for 10 weeks
(Friedman and Tappen, 1991). Patients with cardiovascular
risk factors such as diabetes mellitus and hypertension as well
as those with congestive heart failure were among the
participants. After the treatment period performance on the
Communication Observation Scale (Hoffman et al., 1985)
(Cohen’s dZ1.06) improved only in the walking group.
In other words, patients who went walking showed
an improvement in verbal and non-verbal communication.
In a recent pilot study by Scherder and colleagues
(2005) 43 advanced older individuals with mild cognitive
impairment—a transitional stage to AD (Petersen et al.,
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three treatment groups: a walking group (nZ15), a group
carrying out hand and face exercises (nZ13) and a control
group (nZ15) that received social visits. Patients with
cardiovascular risk factors were not excluded from the
study. Performance on tasks that measure executive function-
ing, verbal ﬂuency and the Trailmaking Test (Reitan and
Wolfson, 1985), improved in both the walking group (Cohen’s
dZ0.42 and dZ0.46, respectively) and the hand/face exercise
group (Cohen’s dZ0.59 and dZ0.13, respectively). However,
considering the small sample size ﬁrm conclusions could not
be drawn.
In sum, the results of the ﬁve studies reviewed above
suggest that exercise has a positive effect on cognition, in
particular attention, memory, communication, executive
functions, and global mental functioning in older persons
with cognitive impairment. However, most studies included
only a small number of people and showed serious
methodological ﬂaws. Two studies did not control for the
presence of cardiovascular risk factors, only one study
excluded those who were familiar with these factors.
5.2. Clinical studies B
One 20-min session of physical activity (walking or arm and
leg extensions) was not found to lead to statistical differences
on a test of language ability and word retrieval or a verbal
recognition task in a group of 25 AD patients. A 20-min session
of Bingo, however, did induce a signiﬁcant improvement on
the tasks (Sobel, 2001). No information was provided about the
presence of cardiovascular risk factors.
A group of 23 moderate to severe AD patients participated
in a programme of endurance exercise that consisted of
walking and riding an exercise bicycle (Rolland et al., 2000).
Patients with cardiac disease were excluded. The AD patients
signiﬁcantly improved in the performance on the MMSE,
implying that global cognitive functioning improved. Unfor-
tunately, a control group was not included. In another
intervention study, 43 older AD patients participated in a
programme consisting of somatic and isotonic-relaxation
exercises (Lindenmuth and Moose, 1990). Information about
the cardiovascular condition of these patients was not
provided. The cognitive abilities of the experimental group
were stated to have improved after 8 weeks of training.
However, the nature of the cognitive abilities that improved
was not further speciﬁed. Moreover, the participants were
allowed to choose whether they preferred to be in the
experimental group or control group, participation in the
exercise group was irregular, and the control group did not
take part in any alternative activity.
Taken together, two out of three studies report an
improvement in global cognitive functioning, by exercise.
The methodological shortcomings of these studies are similar
to those of the clinical studies A. Only one study controlled for
the presence of cardiovascular risk factors and excluded those
who were familiar with them.
6. Discussion
Hypoperfusion, nitric oxide, cognition and exercise in
Alzheimer’s disease.
Cerebral hypoperfusion, characteristic for AD (Miklossy,
2003) and related to a decrease in cerebral metabolism
(Attwell and Iadecola, 2002; Wolf et al., 2001) reduces the
level of cognitive functioning (Miklossy, 2003; Swaab, 1991;
2004). If cerebral hypoperfusion can be restored and kept at
an appropriate level by exercise, one may hypothesize that
collapsed cortical capillaries can participate again in the
circulation. This sequence of events reﬂects the preservation
of the hemodynamic integrity at a capillary level (Miklossy,
2003). In addition, exercise may lower increased blood
pressure (Whelton et al., 2002) and may improve the
cardiovascular condition, i.e. heart rate variability (Pober
et al., 2004), factors that also contribute to the positive effects
of exercise on cerebral perfusion (Critchley et al., 2000;
Keller and Lemberg, 2002).
A theoretical model of the relationship between exercise
and cerebral perfusion is presented in Fig. 3. This model
could serve as a guide for future studies, since it indicates
that exercise is not necessarily beneﬁcial for all people with
dementia, particularly in the presence of ischaemic lesions.
The positive effects of exercise on cerebral perfusion appear
to depend on the patient’s cardiac condition. Koike and
co-workers (2004) observed that in patients with valvular
heart disease, and hence with reduced cardiac output, the
cerebral oxyhemoglobin level declined during increasing
physical effort on a cycle ergometer. These authors suggest
that the blood supply to these patient’s muscle cells during
exercise occurs at the expense of the blood supply to other
organs such as the cerebrum. Others conﬁrm that a limited
cardiac output during exercise with a large muscle mass
affects the regional increase in cerebral perfusion (Ide et al.,
1998). There is ample evidence that cardiovascular disorders
like hypertension increase the risk of AD (Skoog and
Gustafson, 2003; De la Torre, 2002). More speciﬁcally, it
has been observed that high systolic blood pressure
increases the risk for hippocampal atrophy and consequently
the risk for AD (Launer et al., 2000). Kivipelto and
colleagues (2002) describe the important role of hyperten-
sion and hypercholesterolemia in the development and
expression of AD and suggest proper, early interventions
aimed at reducing these cardiovascular risk factors to alter
the incidence of AD. Indeed, ischaemic lesions have been
observed in AD (Koistinaho and Koistinaho, 2005). When
ischaemic lesions are present, (high-intensity) physical
activity might lead to laminin depletion and hence to
neuronal damage (Chen and Strickland, 1997; Nagai et al.,
1999). It, therefore, seems vital to maintain the laminin
concentration at physiologically normal levels. The question
arises to what extent this important information is
incorporated into clinical studies examining the effects of
exercise on cognition of older people with cognitive
impairment.
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Seven of the eight clinical studies reviewed here show
positive effects of physical activity on cognition, in particular
attention, memory, communication, executive functions and
global mental functioning, in older people with dementia. Of
those studies, only two excluded participants who suffered
from hypertension and/or had a history of cardiac problems
(Powell, 1974; Rolland et al., 2000) while four did not control
for cardiovascular risk factors (Diesfeldt and Diesfeldt-
Groenendijk, 1977; Palleschi et al., 1996; Sobel, 2001;
Lindenmuth and Moose, 1990). It may be noted that three of
the last-mentioned four studies reported a beneﬁcial inﬂuence
of exercise on cognition (Diesfeldt and Diesfeldt-Groenendijk,
1977; Palleschi et al., 1996; Lindenmuth and Moose, 1990).
Since we have no evidence that only cognitively impaired older
people without cardiovascular risk factors participated in these
studies, it may be argued that the absence of cardiovascular risk
factors is not a prerequisite for effective treatment. Support for
this argument emerges from two studies reviewed here, which
speciﬁcally included people with cardiovascular risk factors
and where cognitive improvement was still observed
(Friedman and Tappen, 1991; Scherder et al., 2005). The
ﬁndings of the present review do however suggest that the
presence of cardiovascular risk factors might explain those
cases where treatment failed to have a beneﬁcial effect. For
example, in one study where subjects were required to
undertake periods of exercise (walking) combined with
conversation adapted to appeal to patients’ residual verbal
capacities this form of treatment was not found to improve
patients’ overall communication (Cott et al., 2002). (This study
was excluded from the present review, because we did not
consider interventions involving the combination of two types
of sensory stimulation.) The authors mentioned differences in
pre-treatment scores between the experimental group and the
control group as one of the possible reasons for their negative
results. Cardiovascular risk factors (which they did not control
for) might have been an alternative explanation. All in all, it
seems appropriate to suggest that further research into the
effects of physical activity on the cognition of older people
with cognitive impairment should control for cardiovascular
risk factors. On the one hand, this might explain why exercise
is not effective in improving cognition in certain patients, while
on the other it would permit testing of the hypothesis that
greater cognitive improvement is found in patients without
cardiovascular risk factors than in those with this risk.
The fact that only studies of the direct effects of physical
activity on cognition in older people with dementia were
selected might be considered a limitation of the present review.
This restriction was in fact imposed in order to highlight the
paucity of studies of this type. Some authors have suggested
that the strikingly low number of studies in this ﬁeld might be
due to poor patient compliance with the treatment (Tappen
et al., 2000) or patients’ inability to understand the programme
description (Naso et al., 1990). Others found however that frail
persons with dementia are quite capable of following an
exercise programme (Lazowski et al., 1999). It is worth noting
that exercise can also improve cognition indirectly, for
example by reducing depression. Since it is known that
depression can reduce cognitive functioning (Bierman et al.,
2005), a reduction in depression brought about by exercise
(Palmer, 2005) might enhance cognitive functioning. It would
be worthwhile discussing the results of studies of the indirect
effect of exercise on cognition in persons with AD and other
forms of dementia in a subsequent review.
A further limitation of the clinical studies reviewed here is
the relatively small number of patients included, which is due
to the high drop-out rate. The small sample size reduces the
predictive power of the results. However, all studies considered
here gave a positive outcome, though the most informative
effect sizes (Cohen’s d), i.e. those calculated from studies
including both an experimental and a control group, showed an
extremely wide range from dZ0.13 (corresponding to a very
small effect) to dZ1.06 (very large effect).
In conclusion, we recommend that people with AD should
undergo careful physical examination, speciﬁcally aimed at
cardiovascular risk factors, before entering a physical training
programme in future studies. The presence of cardiovascular
Fig. 3. Role of NO, t-PA, plasmin and laminin in effects of exercise in AD. Exercise leads to an upregulation of NO (Endres et al., 2003) and increases cerebral
perfusion which could attenuate endothelial dysfunction in AD. Exercise enhances t-PA (Smith et al., 2003) and consequently plasmin activity, stimulating
degradation ofAband hencereducingneuronaldamage.Ontheother hand,in thepresenceofischaemiclesions,the increasedplasminactivitymaydegradelaminin,
increasing neuronal damage (Chen and Strickland, 1997).
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exercise on cognition. It follows that participation in exercise
programmes next to one’s usual physical activities is not
necessarily beneﬁcial for all patients. A good motto for those
advising persons with dementia on possible exercise regimens
might thus be ‘more is not always better’.
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